Artelo biosciences ceo to appear on benzinga all access on april 23rd at approximately 10:50 am eastern time

Solana beach, calif., april 22, 2024 (globe newswire) -- artelo biosciences, inc.  (nasdaq: artl) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological conditions, today announced that gregory d. gorgas, president and chief executive officer of artelo, will be a featured guest on the benzinga all access show.
ARTL Ratings Summary
ARTL Quant Ranking